Article Sidebar
Views pdf: 43
ANXIETY PREVALENCE AND ASSOCIATED FACTORS IN HOSPITALIZED PATIENTS WITH ULCERATIVE COLITIS AT BACH MAI HOSPITAL
Main Article Content
Abstract
Objective: To determine the prevalence of anxiety and analyze related factors in hospitalized patients with ulcerative colitis (UC).Methods: A cross-sectional descriptive study was conducted on 79 UC patients at Bach Mai Hospital from August 2024 to August 2025. Anxiety was assessed using the Zung Self-Rating Anxiety Scale (SAS). Clinical, paraclinical, and endoscopic factors were collected and analyzed using SPSS 26.0 software with appropriate statistical tests (T-test, Chi-square, logistic regression). Results: The prevalence of anxiety in patients with ulcerative colitis was 43.0%, with 27.8% experiencing mild anxiety and 15.2% experiencing severe anxiety. There was a correlation between anxiety status and disease duration of more than 5 years, severe disease according to the Mayo score, and frequent abdominal pain (p<0.05). Independent factors associated with severe anxiety included a CRP concentration of ≥20 mg/L (OR = 5.1; 95% CI: 2.3-11.4), a white blood cell count of ≥10 G/L (OR = 3.3; 95% CI: 1.4-7.8), and anemia (Hb <100 g/L) (OR = 2.9; 95% CI: 1.2-7.1). Conclusion: The prevalence of anxiety in hospitalized patients with ulcerative colitis is very high and is closely linked to the degree of disease activity and systemic inflammation
Article Details
Keywords
Ulcerative colitis, anxiety, Zung (SAS
References
2. Daperno M, Armuzzi A, Danese S, et al. Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus. Gastroenterol Res Pract. 2019;2019:3108025. doi:10.1155/2019/3108025
3. Fracas E, Costantino A, Vecchi M, Buoli M. Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences? International Journal of Environmental Research and Public Health. 2023; 20(13):6255.
4. Alanazi YWA, Alanazi RSO, Alanazi DAJ, et al. Relationship between inflammatory bowel disease and depressive symptoms in children and adults: A systematic review. Revista iberoamericana de psicología del ejercicio y el deporte. 2024;19(4):463-466.
5. Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN, Jess T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. Nov 2022;19(11):717-726. doi:10.1038/s41575-022-00634-6
6. Nguyễn Thị Hồng. Hiệu quả can thiệp tâm lý trên bệnh nhân viêm loét đại tràng mạn tính có lo âu. Tạp chí Y học TPHCM. 2024;28(2):112-119.
7. Dobre M, Manuc TE, Manuc M, et al. Circulating miRNA Profile in Inflammatory Bowel Disease Patients with Stress, Anxiety, and Depression. Int J Mol Sci. Jul 29 2025;26(15)doi: 10.3390/ijms26157321
8. Piovani D, Armuzzi A, Bonovas S. Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. Apr 3 2024;30(4):573-584. doi:10.1093/ibd/izad109
9. Stroie T, Preda C, Istratescu D, Ciora C, Croitoru A, Diculescu M. Anxiety and depression in patients with inactive inflammatory bowel disease: The role of fatigue and health-related quality of life. Medicine (Baltimore). May 12 2023;102(19): e33713. doi:10.1097/md. 0000000000033713
10. Abu Sneineh A, Haj Ali S, Al-Masri A, et al. Prevalence of anxiety and depressive symptoms in ulcerative colitis patients in Jordan and its relationship to patient-reported disease activity. Sci Rep. May 10 2022;12(1):7682. doi:10.1038/ s41598-022-11911-4